Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

COVID-19 × Observation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 19 Prostatic Neoplasms 18 Carcinoma, Non-Small-Cell Lung 17 Neoplasms 16 Colorectal Neoplasms 14 Endometrial Neoplasms 13 Stomach Neoplasms 12 Lung Neoplasms 11 Pancreatic Neoplasms 9 Leukemia, Myeloid, Acute 7 Colonic Neoplasms 7 Carcinoma, Hepatocellular 7 Oropharyngeal Neoplasms 6 Neoplasm Metastasis 6 Multiple Myeloma 6 Lymphoma, Large B-Cell, Diffuse 6 Esophageal Neoplasms 6 Sarcoma 5 Rectal Neoplasms 5 Mouth Neoplasms 5 Melanoma 5 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Recurrence 4 Head and Neck Neoplasms 4 Colorectal Neoplasms, Hereditary Nonpolyposis 4 Brain Neoplasms 4 Anus Neoplasms 4 Urinary Bladder Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

Standard of Care 7 Surveys and Questionnaires 6 COVID-19 Vaccines 6 Blood Specimen Collection 6 Specimen Handling 5 BNT162 Vaccine 5 2019-nCoV Vaccine mRNA-1273 4 Surgical Procedures, Operative 3 Practice Guidelines as Topic 3 Hydroxychloroquine 3 tocilizumab 2 sotrovimab 2 sinovac COVID-19 vaccine 2 cilgavimab and tixagevimab drug combination 2 Pandemic Preparedness 2 Data Collection 2 CVnCoV COVID-19 vaccine 2 COH04S1 COVID-19 vaccine 2 Azithromycin 2 selinexor 1 remdesivir 1 regorafenib 1 proxalutamide 1 palbociclib 1 ogalvibart 1 monalizumab 1 lenzilumab 1 heterologous prime boost COVID-19 vaccination 1 crexavibart 1 ciclesonide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04442048 2025-12-30

COV-IMMUNO

Canadian Cancer Trials Group

Phase 3 Completed

COVID-19, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡